
Grifols (Nasdaq: GRFS) said it will invest a total of $360 million over 2016-2021, to increase the plasma fractionation capacity …
Novartis has announced the sale of its blood transfusion diagnostics unit to the specialist Spanish firm Grifols for $1.67 billion.Headquartered …
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion

